Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

psychiatric diseases

EU flag

Boehringer’s Vargatef approved in the EU for lung cancer

Marks company’s second oncology drug to hit market

EU flag

Orphan drugs in latest CHMP recommendations

EMA advisers back new products from Genzyme, Boehringer and others

EISAI

Eisai establishes neuroscience unit in Belgium and Luxembourg

Follows the company's recent expansion in Australia

Pharma deals during October 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for October 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

AbbVie is not looking at another big acquisition, says CEO

Unlikely to consider another deal on the scale of failed Shire merger

- PMLiVE

Boehringer and Lilly to restructure diabetes alliance

Say revisions to the alliance will not affect the world's largest markets

- PMLiVE

Biogen Idec appoints senior neuroscientists

Christopher Henderson and Richard Ransohoff make the move from academia

Pharma deals during September 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for September 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

EMG appoints Merck and Boehringer directors as new officers

David Garmon-Jones is new chair and Zinta Krumins is vice chair

UK flag

UK biotech leaders partner on science lobbying

The BIA, Bionow, BioPartner and One Nucleus will work together on influencing government policy

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links